In terms of heart failure, cardiac apelin expression has been shown to be reduced in experimental left ventricular hypertrophy and heart failure comprising Dahl salt-sensitive rats, which was reversed by treatment with the AT1receptor blocker telmisartan [153]. This evidence concerns the gene APLN and left ventricular hypertrophy.